论文部分内容阅读
早发急性心肌梗死(acute myocardial infarction,AMI)是一种罕见的疾病,发病率和死亡率很高。该文在再灌注治疗广泛应用的大环境下,纳入前瞻性研究人群进行早发AMI的预后研究。方法:这项前瞻性多中心研究中连续纳入102例AMI存活者(≤40岁),临床预后通过奥地利死亡登记处和维也纳集中患者管理系统进行查询。结果:在10.3年的中位随访时
Early onset of acute myocardial infarction (AMI) is a rare disease with high morbidity and mortality. In the context of reperfusion therapy is widely used in the context of prospective study population included in the prognosis of AMI. METHODS: A total of 102 AMI survivors (≤40 years) were enrolled in this prospective multicenter study. The clinical outcome was investigated through the Austrian Registry of Deaths and the Vienna-based Patient Management System. Results: At a median follow-up of 10.3 years